Man Group
BSTC

Man Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Man Group’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-37,391
Closed -$1.98M – 2011
2020
Q3 		$1.98M Buy
37,391
+9,780
+35% +$604K 0.01% 1199
2020
Q2 		$1.69M Sell
27,611
-5,550
-17% -$321K 0.01% 1119
2020
Q1 		$1.88M Sell
33,161
-12,304
-27% -$701K 0.01% 909
2019
Q4 		$2.59M Buy
45,465
+3,379
+8% +$179K 0.01% 1254
2019
Q3 		$2.25M Buy
42,086
+2,800
+7% +$163K 0.01% 1206
2019
Q2 		$2.35M Buy
39,286
+5,323
+16% +$335K 0.01% 1259
2019
Q1 		$2.12M Sell
33,963
-100
-0.3% -$6.62K 0.01% 1314
2018
Q4 		$2.06M Sell
34,063
-100
-0.3% -$5.97K 0.01% 1209
2018
Q3 		$2M Buy
34,163
+800
+2% +$40.8K 0.01% 1424
2018
Q2 		$1.5M Sell
33,363
-4,060
-11% -$175K 0.01% 1476
2018
Q1 		$1.66M Buy
+37,423
New +$1.57M 0.01% 1354

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Man Group's BSTC Position: Q4 2020 in Review

Man Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 37,391 shares — an estimated $1.98M sold.

Man Group first reported a position in BSTC in Q1 2018 and held it in 11 quarters. The position peaked at $2.59M in Q4 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • Man Group reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • Man Group sold 37,391 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1.98M.
  • Man Group first reported a position in BioSpecifics Technologies Corp. in Q1 2018 and held it in 11 quarters.
  • Man Group's BioSpecifics Technologies Corp. position peaked at $2.59M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Man Group's 13F filing for Q4 2020, filed 16 Feb 2021.